2009
DOI: 10.1186/1471-230x-9-53
|View full text |Cite
|
Sign up to set email alerts
|

TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells

Abstract: BackgroundPhosphatidylcholine (PC) is a major lipid of the gastrointestinal mucus layer. We recently showed that mucus from patients suffering from ulcerative colitis has low levels of PC. Clinical studies reveal that the therapeutic addition of PC to the colonic mucus using slow release preparations is beneficial. The positive role of PC in this disease is still unclear; however, we have recently shown that PC has an intrinsic anti-inflammatory property. It could be demonstrated that the exogenous application… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
61
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 95 publications
(65 citation statements)
references
References 66 publications
4
61
0
Order By: Relevance
“…With regard to the mechanisms of counteracting the TNF-␣ effects, it is unlikely that the soluble factors in the LP-CS prevented the cytokine from binding to their receptors. This is because the supernatant was added apically, whereas TNF-␣ was added to the basolateral medium, as the receptors for TNF-␣ are known to be localized to the basolateral membranes of polarized IECs (32,43). Therefore, the activity of the LP-CS to counteract the TNF-␣ effects on SMCT1 expression and function appears to involve mechanisms independent of TNF-␣ binding to its receptors.…”
Section: Discussionmentioning
confidence: 99%
“…With regard to the mechanisms of counteracting the TNF-␣ effects, it is unlikely that the soluble factors in the LP-CS prevented the cytokine from binding to their receptors. This is because the supernatant was added apically, whereas TNF-␣ was added to the basolateral medium, as the receptors for TNF-␣ are known to be localized to the basolateral membranes of polarized IECs (32,43). Therefore, the activity of the LP-CS to counteract the TNF-␣ effects on SMCT1 expression and function appears to involve mechanisms independent of TNF-␣ binding to its receptors.…”
Section: Discussionmentioning
confidence: 99%
“…GPC acts as a PC precursor (Gallazzini and Burg 2009), and the increased uptake of membrane-forming phospholipids, including PC, proved to exert an anti-infl ammatory infl uence in other experimental studies (Chao et al 1995, El-Hariri et al 1992, Er ő s et al 2009). Previous investigation revealed that PC treatment prevented microglia accumulation in the hippocampus (T ő k é s et al 2011), and further evidence for the mechanism of action is provided by recent in vitro fi ndings of an anti-TNF -a eff ect and specifi c inhibition of the Toll-like receptor 4-dependent infl ammatory pathway (Ishikado et al 2009, Treede et al 2009.…”
Section: Discussionmentioning
confidence: 99%
“…38) Luminal applications of PC and LPC were reported to exert an anti-inflammatory effect on rat intestinal mucosa by reducing the up-regulation of proinflammatory cytokines induced by tumor necrosis factor-α (TNF-α)/nuclear factor κB, possibly through its incorporation into the lipid raft of the plasma membranes. 39) The shift in the phospholipid composition of the gastric mucus toward an increased ratio of LPC to PC might be induced by PLA 2 activity in humans infected with Helicobacter pylori, and thus impair the ability of the barrier to protect against bacterial pathogens and high-molecular weight components in foods. 40) Pretreatment with PC with one or two polyunsaturated fatty acyl groups prevented cold restraint stress-induced 41) and ethanol-and indomethacin-induced gastric ulcers in rats.…”
Section: Pc Concentrations In Digestive Tractsmentioning
confidence: 99%